Our comprehensive guide hospitals information helps you quickly locate a hospital anywhere in the world. Our database contains in excess of 16,000 hospitals, making it one of the best places to find information on the hospital you are searching for. To assist you with locating a hospital, you can refine your search by selecting the country in which the hospital is located and choose to search by either hospital name, city/town or state/county.

 Home>> Kalbitor (ecallantide)

Kalbitor (ecallantide)

General Information

Kalbitor (ecallantide) is a human plasma kallikrein inhibitor.

Kalbitor is specifically indicated for the treatment of acute attacks of hereditary angioedema in patients 16 years of age and older.

Kalbitor is supplied as a solution for subcutaneous administration. The recommended initial dose is 30 mg (3 mL), administered subcutaneously in three 10 mg (1 mL) injections. If the attack persists, an additional dose of 30 mg may be administered within a 24 hour period.


Additional Information

For additional information regarding Kalbitor or acute attacks of hereditary angioedema, please visit the Kalbitor web page.

Clinical Results

FDA Approval
The FDA approval of Kalbitor was based on the results of two placebo-controlled phase 3 clinical studies, known as EDEMA3 and EDEMA4. In both trials, the effects of Kalbitor were evaluated using the Mean Symptom Complex Severity (MSCS) score and the Treatment Outcome Score (TOS).

EDEMA3
This randomized, double-blind, placebo-controlled trial enrolled 72 subjects who were randomized to receive Kalbitor or placebo for acute attacks of HAE. The primary endpoint was the TOS at 4 hours, and the key secondary efficacy endpoint was the change from baseline in MSCS at 4 hours. Kalbitor demonstrated a greater decrease from baseline in the MSCS (p=0.041) than placebo and a greater TOS (p=0.045) than patients treated with placebo; these results were statistically significant. In addition, more patients in the placebo group (36%) required medical intervention to treat unresolved symptoms within 24 hours compared to the Kalbitor-treated group (14%).

EDEMA4
This randomized, double-blind, placebo-controlled trial enrolled 96 patients who were randomized to receive Kalbitor 30 mg subcutaneous or placebo for acute attacks of HAE. The primary endpoint was the change from baseline in MSCS score at 4 hours, and the TOS at 4 hours was a key secondary endpoint. Patients treated with Kalbitor demonstrated a greater decrease from baseline in the MSCS (p=0.010) than placebo and a greater TOS (p=0.003) than patients with placebo; these results were statistically significant. At 24 hours, patients treated with Kalbitor also demonstrated a greater decrease from baseline in the MSCS than placebo (-1.5 vs. -1.1; p = 0.04) and a greater TOS (89 vs. 55, p = 0.03). More patients in the placebo group (50%) required medical intervention to treat unresolved symptoms within 24 hours compared to the Kalbitor-treated group (33%).


Mechanism of Action

Kalbitor (ecallantide) is a human plasma kallikrein inhibitor. Hereditary angioedema is a genetic disorder caused by mutations to C1-esterase-inhibitor (C1-INH). It is characterized by low levels of C 1 - INH activity and low levels of C4. C 1 - INH functions to regulate the activation of the complement and intrinsic coagulation (contact system pathway) and is a major endogenous inhibitor of plasma kallikrein. The kallikrein-kinin system is a complex proteolytic cascade involved in the initiation of both inflammatory and coagulation pathways. One critical aspect of this pathway is the conversion of High Molecular Weight (HMW) kininogen to bradykinin by the protease plasma kallikrein. In HAE, normal regulation of plasma kallikrein activity and the classical complement cascade is therefore not present. During attacks, unregulated activity of plasma kallikrein results in excessive bradykinin generation. Bradykinin is a vasodilator which is thought by some to be responsible for the characteristic HAE symptoms of localized swelling, inflammation, and pain


Literature References

Side effects

Adverse events associated with the use of Kalbitor may include, but are not limited to, the following:

  • Headache
  • Nausea
  • Fatigue
  • Diarrhea
  • Upper respiratory tract infection
  • Injection site reactions
  • Nasopharyngitis
  • Vomiting
  • Puritus
  • Uupper abdominal pain
  • Pyrexia


Treatment

hereditary angioedema

Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Cinqair (reslizumab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print REPRONEX(menotropins for injection, USP) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Potiga (ezogabine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Oleptro (trazodone hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Benzamycin (erythromycin 3%-benzoyl peroxide 5% topical gel) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Opdivo (nivolumab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Zurampic (lesinurad) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Belviq (lorcaserin hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Amturnide (aliskiren + amlodipine + hydrochlorothiazide) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print ReoPro Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Asacol (mesalamine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Provenge (sipuleucel-T) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rexulti (brexpiprazole) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Akynzeo (netupitant and palonosetron) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Qsymia (phentermine + topiramate extended-release) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rebetol (ribavirin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Allegra (fexofenadine hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Androderm (Testosterone Transdermal System) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Ranitidine Tablets Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Renvela (sevelamer carbonate) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Verapamil Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Proscar Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Addyi (flibanserin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Qutenza (capsaicin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prolia (denosumab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Aciphex (rabeprazole sodium) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Onsolis (fentanyl buccal) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Alora Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Ranitidine Capsules Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Avonex (Interferon Beta 1-A) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Pediarix Vaccine Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Remeron SolTab (mirtazapine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Cetrotide Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Onzetra Xsail (sumatriptan nasal powder) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rayos (prednisone) delayed-release tablets Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Arnuity Ellipta (fluticasone furoate inhalation powder) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Alphagan (brimonidine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Orfadin (nitisinone) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Altocor (lovastatin) Extended-Release Tablets Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Precose (acarbose)